Greg Leonberger, FSA, EA, MAAA, FCA
Partner, Director of Research
Last week was a painful one for the equity markets as fears about the coronavirus drove investors out of stocks and markets into correction territory. The following newsletter summarizes last week’s developments and provides specific commentary on what to watch for across the major asset classes that constitute investor portfolios.
Read > March 2: Coronavirus Update and Portfolio Guidance
As always, please reach out to your consultant or our research team for more details about any of the information presented in this update. For more Marquette coverage on coronavirus, reference our previous newsletter (January 28) and Chart of the Week posts (February 13, February 21, February 26).
The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.
07.24.2026
This video is a recording of a live webinar held July 23 by Marquette’s research team analyzing the first half…
07.22.2026
The usual midyear version of these letters has touched on year-to-date performance as well as the most influential macroeconomic and…
07.20.2026
Our most recent Chart of the Week publication discussed how the AI investment opportunity has expanded beyond…
07.13.2026
One of the enduring lessons of the California Gold Rush is that the greatest fortunes were often made not by…
07.06.2026
Since traditional exit routes have remained constrained in recent years due to higher interest rates, valuation gaps, and a subdued…
06.29.2026
This week’s chart highlights the varying return profiles across key infrastructure sectors by illustrating the split between income and capital…
Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.
We respect your privacy. We will never share or sell your information.
If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.
Contact Us >